SHOUCHENGBIO offers undenatured type II collagen extracted from chicken sternum cartilage. The ingredient is produced via low-temperature patented extraction technology, which preserves the complete triple-helix molecular structure of collagen. With defined active content and supporting clinical data, this ingredient is suitable for joint health supplement brands, sports nutrition manufacturers, and premium supplement enterprises engaged in commercial procurement. Batch traceability documentation is available for all production lots to support quality management processes for enterprise customers. The product targets formulation development for advanced joint support products.
Item | Details |
|---|---|
Manufacturing Process | Low - temperature patented extraction technology |
Molecular Structure | Triple - helix molecular structure is intact |
Product Water - solubility | Semi - water - soluble, with good activity and absorption |
Efficacy Principle | Promotes the growth, repair, and regeneration of cartilage and tissues |
The ingredient is classified as a macromolecular collagen material. It is insoluble in water and ethanol, and retains structural integrity through the extraction process. Multiple clinical research datasets support its application in joint health formulations.
Items | Standard |
|---|---|
Appearance | Off white powder |
Taste and Odor | Slightly salty, with characteristic odor of this product |
Impurity | No visible exogenous impurity |
Stacking Density, g/ml | ----- |
Mucopolysaccharide | ≥26.0 |
Undenatured Type II Collagen, g/100g | ≥15.0 |
Protein, g/100g | ≥60.0 |
Ash, g/100g | ≤8.0 |
Moisture, g/100g | ≤10.0 |
pH (2% aqueous solution) | 5.0 - 7.0 |
Fat (g/100g) | ≤6.0 |
Lead, mg/kg | ≤0.9 |
Cadmium, mg/kg | ≤0.1 |
Arsenic, mg/kg | ≤1.0 |
Chromium, mg/kg | ≤2.0 |
Mercury, mg/kg | ≤0.1 |
Total plate count, CFU/g | n=5, c=2, m= 104, M= 105 |
Coliforms, CFU/g | n=5, c=2, m= 10, M= 100 |
Undenatured type II collagen supports joint lubrication and promotes the repair and regeneration of joint cartilage. It also modulates joint inflammatory cytokines to support joint comfort. These properties make the ingredient suitable for formulations targeting degenerative joint conditions and daily joint maintenance.
The ingredient supports increased bone density, and contributes to the repair, reconstruction and regeneration of osteonecrosis of the femoral head. It also supports improved fracture healing ability. These functions expand its application into bone health and orthopedic recovery support formulations.
For sports nutrition products, the ingredient supports joint nutrition and improved emergency response ability and explosive power. It fits into premium sports nutrition lines targeting athletes and active individuals seeking joint support alongside performance support.
For general joint health maintenance products, a daily intake of 400mg undenatured type II collagen is suggested, typically delivered in two 200mg capsules. For products targeting users with existing joint discomfort, formulations may use 600mg daily for the initial 8 weeks, followed by 400mg daily for maintenance.
For optimal absorption, the ingredient is intended for consumption 30–60 minutes before meals on an empty stomach, with 250ml of water. This timing supports uptake via intestinal transporters into the bloodstream. Formulators may include this guidance in end-product labeling.
Clinical research shows measurable changes in joint function scores after 8 weeks of consistent use, with maximum benefits typically observed at 12 weeks. Continued use is recommended to maintain long-term results. Formulators may reference this timeline for product usage instructions.
Formulation outcomes may be enhanced when combined with 1000mg daily omega-3 fatty acids for anti-inflammatory support, and 500mg daily vitamin C to support collagen synthesis. Calcium supplements should be administered at least 2 hours apart from this ingredient to avoid potential absorption interference.
Unlike hydrolyzed collagen, which provides amino acid building blocks, undenatured type II collagen interacts with immune cells in joint tissues to modulate inflammatory responses and support cartilage maintenance. This immunomodulatory effect supports preservation of existing cartilage structure.
The product is derived exclusively from chicken sternum and does not contain common allergens including shellfish, soy, dairy, or gluten. It undergoes testing to verify allergen absence, with detection limits below 1ppm for common allergens.
There are no documented interactions with common medications. However, individuals taking immunosuppressive drugs should consult a healthcare provider before use, as the product may influence immune regulatory pathways in joint tissues.
A randomized controlled trial with 120 participants showed a 37% improvement in joint pain scores and a 42% improvement in mobility after 90 days of use. A separate study demonstrated measurable increases in cartilage thickness markers in 78% of users after 6 months.
Glucosamine supports glycosaminoglycan synthesis, while undenatured type II collagen works through immune regulation in joint tissue. The two ingredients operate through different biological mechanisms, and many formulators combine them for comprehensive joint support products.
